Casdin Capital’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $837K | Hold |
165,323
| – | – | 0.08% | 28 |
|
|
2025
Q1 | $875K | Hold |
165,323
| – | – | 0.07% | 38 |
|
|
2024
Q4 | $1.12M | Buy |
+165,323
| New | +$1.12M | 0.07% | 34 |
|
|
2022
Q2 | – | Sell |
-548,156
| Closed | -$3.93M | – | 47 |
|
|
2022
Q1 | $3.93M | Hold |
548,156
| – | – | 0.18% | 44 |
|
|
2021
Q4 | $9.39M | Hold |
548,156
| – | – | 0.26% | 45 |
|
|
2021
Q3 | $12.6M | Hold |
548,156
| – | – | 0.31% | 42 |
|
|
2021
Q2 | $20M | Buy |
+548,156
| New | +$20M | 0.51% | 37 |
|